RaminR.GhazizadehRaminR. i inni, Pathogenic mechanisms shared between psoriasis and cardiovascular disease, „International Journal of Medical Sciences”, 7 (5), 2010, s. 284–289, DOI: 10.7150/ijms.7.284, PMID: 20827428, PMCID: PMC2934727(ang.).
Stephanie L.S.L.MehlisStephanie L.S.L., Kenneth B.K.B.GordonKenneth B.K.B., The immunology of psoriasis and biologic immunotherapy, „Journal of the American Academy of Dermatology”, 49 (2 Suppl), 2003, S44–50, DOI: 10.1016/s0190-9622(03)01134-4, PMID: 12894125(ang.).
AlexanderA.EgebergAlexanderA. i inni, Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study, „JAMA dermatology”, 151 (11), 2015, s. 1200–1205, DOI: 10.1001/jamadermatol.2015.1986, ISSN2168-6084, PMID: 26222707 [dostęp 2020-06-19](ang.).
Jason E.J.E.HawkesJason E.J.E. i inni, Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis, „The Journal of Immunology”, 201 (6), 2018, s. 1605–1613, DOI: 10.4049/jimmunol.1800013, PMID: 30181299, PMCID: PMC6129988(ang.).
Maria Lúcia DinizM.L.D.AraujoMaria Lúcia DinizM.L.D., Maria Goretti P. de A.M.G.P.A.BurgosMaria Goretti P. de A.M.G.P.A., Isis Suruagy CorreiaI.S.C.MouraIsis Suruagy CorreiaI.S.C., Influências nutricionais na psoríase, „Anais Brasileiros De Dermatologia”, 84 (1), 2009, s. 90–92, DOI: 10.1590/s0365-05962009000100016, PMID: 19377768(port.).
M.M.WoltersM.M., Diet and psoriasis: experimental data and clinical evidence, „The British Journal of Dermatology”, 153 (4), 2005, s. 706–714, DOI: 10.1111/j.1365-2133.2005.06781.x, PMID: 16181450(ang.).
GiovanniG.AddoloratoGiovanniG. i inni, Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature, „Digestion”, 68 (1), 2003, s. 9–12, DOI: 10.1159/000073220, PMID: 12949434(ang.).
ClaudioC.GalliClaudioC., Philip C.P.C.CalderPhilip C.P.C., Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review, „Annals of Nutrition & Metabolism”, 55 (1-3), 2009, s. 123–139, DOI: 10.1159/000228999, PMID: 19752539(ang.).
D.D.MetzeD.D. i inni, Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases, „Journal of the American Academy of Dermatology”, 41 (4), 1999, s. 533–539, DOI: 10.1016/S0190-9622(99)80048-6, PMID: 10495371(ang.).
A.A.BruneA.A. i inni, Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon. Offene, nicht placebokontrollierte Anwendung bei 133 Patienten, „Der Hautarzt”, 55 (12), 2004, s. 1130–1136, DOI: 10.1007/s00105-004-0802-8, PMID: 15517116(niem.).
RaminR.GhazizadehRaminR. i inni, Pathogenic mechanisms shared between psoriasis and cardiovascular disease, „International Journal of Medical Sciences”, 7 (5), 2010, s. 284–289, DOI: 10.7150/ijms.7.284, PMID: 20827428, PMCID: PMC2934727(ang.).
Stephanie L.S.L.MehlisStephanie L.S.L., Kenneth B.K.B.GordonKenneth B.K.B., The immunology of psoriasis and biologic immunotherapy, „Journal of the American Academy of Dermatology”, 49 (2 Suppl), 2003, S44–50, DOI: 10.1016/s0190-9622(03)01134-4, PMID: 12894125(ang.).
AlexanderA.EgebergAlexanderA. i inni, Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study, „JAMA dermatology”, 151 (11), 2015, s. 1200–1205, DOI: 10.1001/jamadermatol.2015.1986, ISSN2168-6084, PMID: 26222707 [dostęp 2020-06-19](ang.).
Jason E.J.E.HawkesJason E.J.E. i inni, Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis, „The Journal of Immunology”, 201 (6), 2018, s. 1605–1613, DOI: 10.4049/jimmunol.1800013, PMID: 30181299, PMCID: PMC6129988(ang.).
Maria Lúcia DinizM.L.D.AraujoMaria Lúcia DinizM.L.D., Maria Goretti P. de A.M.G.P.A.BurgosMaria Goretti P. de A.M.G.P.A., Isis Suruagy CorreiaI.S.C.MouraIsis Suruagy CorreiaI.S.C., Influências nutricionais na psoríase, „Anais Brasileiros De Dermatologia”, 84 (1), 2009, s. 90–92, DOI: 10.1590/s0365-05962009000100016, PMID: 19377768(port.).
M.M.WoltersM.M., Diet and psoriasis: experimental data and clinical evidence, „The British Journal of Dermatology”, 153 (4), 2005, s. 706–714, DOI: 10.1111/j.1365-2133.2005.06781.x, PMID: 16181450(ang.).
GiovanniG.AddoloratoGiovanniG. i inni, Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature, „Digestion”, 68 (1), 2003, s. 9–12, DOI: 10.1159/000073220, PMID: 12949434(ang.).
ClaudioC.GalliClaudioC., Philip C.P.C.CalderPhilip C.P.C., Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review, „Annals of Nutrition & Metabolism”, 55 (1-3), 2009, s. 123–139, DOI: 10.1159/000228999, PMID: 19752539(ang.).
D.D.MetzeD.D. i inni, Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases, „Journal of the American Academy of Dermatology”, 41 (4), 1999, s. 533–539, DOI: 10.1016/S0190-9622(99)80048-6, PMID: 10495371(ang.).
A.A.BruneA.A. i inni, Antipruritische Therapie mit dem oralen Opiatrezeptorantagonisten Naltrexon. Offene, nicht placebokontrollierte Anwendung bei 133 Patienten, „Der Hautarzt”, 55 (12), 2004, s. 1130–1136, DOI: 10.1007/s00105-004-0802-8, PMID: 15517116(niem.).
AlexanderA.EgebergAlexanderA. i inni, Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study, „JAMA dermatology”, 151 (11), 2015, s. 1200–1205, DOI: 10.1001/jamadermatol.2015.1986, ISSN2168-6084, PMID: 26222707 [dostęp 2020-06-19](ang.).